Effects of a new aldose reductase inhibitor on various tissues in vitro - PubMed (original) (raw)
. 1984 Apr;229(1):226-30.
- PMID: 6423811
Effects of a new aldose reductase inhibitor on various tissues in vitro
H Terashima et al. J Pharmacol Exp Ther. 1984 Apr.
Abstract
A new aldose reductase inhibitor, ONO-2235 [(E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene] rhodanine], was found to possess a potent inhibitory activity of aldose reductase, partially purified from rat lens (IC50 = 1.0 X 10(-8) M) and human placenta (IC50 = 2.6 X 10(-8) M). Against rat lens aldose reductase, ONO-2235 exhibited uncompetitive inhibition as previously observed with 7-hydroxy-4-oxo-4H-chromen-2-carboxylic acid. Sorbitol accumulation in the isolated rat lenses, sciatic nerves and human erythrocytes were all effectively inhibited during incubation with high concentrations of glucose (28-50 mM) by ONO-2235 at a concentration of about 10(-6) M. Because the accumulation of sorbitol has been reported to play an etiological role in the development of diabetic complications, the results suggest that ONO-2235 may prove to be useful in preventing and improving some diabetic complications.
Similar articles
- Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T, Tsuboshima M. Kikkawa R, et al. Diabetologia. 1983 Apr;24(4):290-2. doi: 10.1007/BF00282716. Diabetologia. 1983. PMID: 6407887 - Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix.
Aida K, Tawata M, Shindo H, Onaya T, Sasaki H, Yamaguchi T, Chin M, Mitsuhashi H. Aida K, et al. Planta Med. 1990 Jun;56(3):254-8. doi: 10.1055/s-2006-960950. Planta Med. 1990. PMID: 2118267 - Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats.
Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y. Kikkawa R, et al. Metabolism. 1984 Mar;33(3):212-4. doi: 10.1016/0026-0495(84)90038-6. Metabolism. 1984. PMID: 6420645 - Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ 3rd, Abobo CV, Carter BL, Ball DW. Zenon GJ 3rd, et al. Clin Pharm. 1990 Jun;9(6):446-57. Clin Pharm. 1990. PMID: 2114249 Review. - Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
Ramirez MA, Borja NL. Ramirez MA, et al. Pharmacotherapy. 2008 May;28(5):646-55. doi: 10.1592/phco.28.5.646. Pharmacotherapy. 2008. PMID: 18447661 Review.
Cited by
- Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights.
Hamdi A, Yaseen M, Ewes WA, Bhat MA, Ziedan NI, El-Shafey HW, Mohamed AAB, Elnagar MR, Haikal A, Othman DIA, Elgazar AA, Abusabaa AHA, Abdelrahman KS, Soltan OM, Elbadawi MM. Hamdi A, et al. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2231170. doi: 10.1080/14756366.2023.2231170. J Enzyme Inhib Med Chem. 2023. PMID: 37470409 Free PMC article. - Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation.
Castellví A, Crespo I, Crosas E, Cámara-Artigas A, Gavira JA, Aranda MAG, Parés X, Farrés J, Juanhuix J. Castellví A, et al. Sci Rep. 2019 Feb 28;9(1):3177. doi: 10.1038/s41598-019-39722-0. Sci Rep. 2019. PMID: 30816220 Free PMC article. - Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats.
Yang BB, Hong ZW, Zhang Z, Yu W, Song T, Zhu LL, Jiang HS, Chen GT, Chen Y, Dai YT. Yang BB, et al. Int J Impot Res. 2019 Mar;31(2):97-104. doi: 10.1038/s41443-018-0075-x. Epub 2018 Sep 13. Int J Impot Res. 2019. PMID: 30214006 Free PMC article. - Synthesis and Biological Evaluation of Novel Gigantol Derivatives as Potential Agents in Prevention of Diabetic Cataract.
Wu J, Lu C, Li X, Fang H, Wan W, Yang Q, Sun X, Wang M, Hu X, Chen CY, Wei X. Wu J, et al. PLoS One. 2015 Oct 30;10(10):e0141092. doi: 10.1371/journal.pone.0141092. eCollection 2015. PLoS One. 2015. PMID: 26517726 Free PMC article. - Litsea japonica Extract Inhibits Aldose Reductase Activity and Hyperglycemia-Induced Lenticular Sorbitol Accumulation in db/db Mice.
Kim J, Kim CS, Sohn E, Lee YM, Jo K, Kim JS. Kim J, et al. Evid Based Complement Alternat Med. 2015;2015:747830. doi: 10.1155/2015/747830. Epub 2015 Feb 23. Evid Based Complement Alternat Med. 2015. PMID: 25802544 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources